Literature DB >> 18624793

Inter-laboratory assessment of PrPSc typing in creutzfeldt-jakob disease: a Western blot study within the NeuroPrion Consortium.

Piero Parchi1, Silvio Notari, Petra Weber, Heinz Schimmel, Herbert Budka, Isidre Ferrer, Stéphane Haik, Jean-Jacques Hauw, Mark W Head, James W Ironside, Lucia Limido, Agustin Rodriguez, Thomas Ströbel, Fabrizio Tagliavini, Hans A Kretzschmar.   

Abstract

Molecular typing is of considerable importance for the surveillance and epidemiology of human transmissible spongiform encephalopathies (TSEs). It relies on the detection of distinct protease-resistant prion protein (PrP(Sc)) core fragments that differ in molecular mass and/or glycoform ratio. In this collaborative study, we tested the inter-laboratory agreement in TSE molecular typing. Sixteen characterized brain specimens from sporadic TSEs and variant Creutzfeldt-Jakob disease (vCJD) cases were distributed blindly to seven laboratories for molecular characterization by a defined protocol and classification. Agreement between laboratories in the classification of samples was excellent. In particular, there were no differences in the distinction between PrP(Sc) type 1, type 2A, and type 2B with one exception, which eventually was identified as a case with types 1 and 2 co-occurrence. This shows that the general technique and particular classification system used here are robust and represent a reliable basis for diagnostic and epidemiologic purposes. The subtle further distinction of subtypes among type 1 and type 2 groups requires high-sensitivity gel electrophoresis protocols that are unsuitable for routine diagnostic needs and must be reserved for research investigations. Further research is necessary on the identification and significance of co-occurrence of PrP(Sc) types 1 and 2 within one brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624793     DOI: 10.1111/j.1750-3639.2008.00187.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  24 in total

1.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

2.  Coinfecting prion strains compete for a limiting cellular resource.

Authors:  Ronald A Shikiya; Jacob I Ayers; Charles R Schutt; Anthony E Kincaid; Jason C Bartz
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

Review 3.  Extracellular vesicles with diagnostic and therapeutic potential for prion diseases.

Authors:  Arun Khadka; Jereme G Spiers; Lesley Cheng; Andrew F Hill
Journal:  Cell Tissue Res       Date:  2022-04-08       Impact factor: 5.249

4.  Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP.

Authors:  Casper Jansen; Piero Parchi; Sabina Capellari; Ad J Vermeij; Patrizia Corrado; Frank Baas; Rosaria Strammiello; Willem A van Gool; John C van Swieten; Annemieke J M Rozemuller
Journal:  Acta Neuropathol       Date:  2009-11-13       Impact factor: 17.088

5.  Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.

Authors:  Anna Bartoletti-Stella; Patrizia Corrado; Nicola Mometto; Simone Baiardi; Pascal F Durrenberger; Thomas Arzberger; Richard Reynolds; Hans Kretzschmar; Sabina Capellari; Piero Parchi
Journal:  Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.590

6.  Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA.

Authors:  Piero Parchi; Laura de Boni; Daniela Saverioni; Mark L Cohen; Isidro Ferrer; Pierluigi Gambetti; Ellen Gelpi; Giorgio Giaccone; Jean-Jacques Hauw; Romana Höftberger; James W Ironside; Casper Jansen; Gabor G Kovacs; Annemieke Rozemuller; Danielle Seilhean; Fabrizio Tagliavini; Armin Giese; Hans A Kretzschmar
Journal:  Acta Neuropathol       Date:  2012-06-30       Impact factor: 17.088

7.  The Three Glycotypes in the London Classification System of Sporadic Creutzfeldt-Jakob Disease Differ in Disease Duration.

Authors:  Blair Ney; Dhamidhu Eratne; Victoria Lewis; Luke Ney; Qiao-Xin Li; Christiane Stehmann; Steven Collins; Dennis Velakoulis
Journal:  Mol Neurobiol       Date:  2021-04-26       Impact factor: 5.590

Review 8.  Molecular pathology of human prion disease.

Authors:  Jonathan D F Wadsworth; John Collinge
Journal:  Acta Neuropathol       Date:  2010-08-08       Impact factor: 17.088

Review 9.  Review: contribution of transgenic models to understanding human prion disease.

Authors:  J D F Wadsworth; E A Asante; J Collinge
Journal:  Neuropathol Appl Neurobiol       Date:  2010-12       Impact factor: 8.090

10.  Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification.

Authors:  Piero Parchi; Rosaria Strammiello; Silvio Notari; Armin Giese; Jan P M Langeveld; Anna Ladogana; Inga Zerr; Federico Roncaroli; Patrich Cras; Bernardino Ghetti; Maurizio Pocchiari; Hans Kretzschmar; Sabina Capellari
Journal:  Acta Neuropathol       Date:  2009-08-29       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.